↓ Figure 2. The MFC analysis included
sequentially: CD45/side scatter, CD45+++/CD3+, and
CD3+/CD10+, with further phenotypic characterization using CD4, CD5, CD7, and CD8.
The analysis disclosed a small circulating population of atypical T cells (in red) expressing
CD3+, CD10+, bimodal CD7+, and negativity for CD8, with strong
positivity for CD5 and reduced expression of CD4, if compared to normal T CD4+ and
CD8+ cell counterparts (in green). MFC: multiparametric flow cytometry.
↓ Figure 3. nTFHL-AI cells (in red) were negative
for TRBC1 JOVI-1, confirming the T-cell clonal restriction. The normal T CD4+ and
CD8+ cell counterpart (in green) showed bimodal expression of TRBC1 JOVI-1, indicating
polyclonality. nTFHL-AI: nodal T-follicular helper cell lymphoma angioimmunoblastic type; TRBC1:
TCRβ-chain constant region 1.
↓ Figure 4. (a) Small to medium-sized T
CD4+ cells surrounding endothelial venules (red arrow) and a proliferation of follicular
dendritic cells (blue arrow) were variably detected. (b) Accompanying polymorphic inflammatory cells and
CD8+ granzyme+ T cells were observed. The atypical T-cell population expressed
CD10+ (c), CD5+ (d), with partial expression of CD7 (e), and CD30 (f).